CLINICAL_TRIALS
withdrawal
· 2024-05-10
Clinical Trial Update: Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.
Summary
Clinical trial NCT04556279 investigating salt taste thresholds in patients with primary hyperaldosteronism before and after treatment has been withdrawn, per sp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Imperial College London | Conditions: Hyperaldosteronism; Primary, Hypertension | Status: WITHDRAWN